Skip to main content
. 2017 Dec 11;9(5):5993–6006. doi: 10.18632/oncotarget.23202

Figure 1. Inhibitory effects of Scutellarein on AGS and SNU-484 Gastric cancer cells.

Figure 1

(A–B) Both the gastric cancer cells were treated with indicated concentrations (0, 25, 50, 75 and 100 μM) of scutellarein for 24 h and 48 h. Cell viability was determined by a MTT assay. (C–D) Cell proliferation curves of AGS and SNU-484 cells treated scutellarein for 24 h and 48 h with or without Scutellarein. The data are expressed as the mean ± standard deviation (SD) of at least three independent experiments. (**P < 0.05, ***P < 0.01 compared to control).